EYPT — EYEPOINT PHARMACEUTICALS INC

Ownership history in CITADEL ADVISORS LLC  ·  55 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported EYEPOINT PHARMACEUTICALS INC (EYPT) in 55 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 0.01% in 2023 Q4. The latest visible filing shows EYPT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this EYPT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in EYEPOINT PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

EYPT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

EYPT stock page CITADEL ADVISORS LLC fund profile CITADEL ADVISORS LLC full holdings
How CITADEL ADVISORS LLC held EYPT — position size vs. price
% of Fund (quarterly)    EYPT price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 26 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 63,200 +25,900 +69.4% 0.00% $1.2M 2026-02-14 (Est.) $12.94
2025 Q4 REDUCED 37,300 -50,900 -57.7% 0.00% $681K 2026-02-14 (Est.) $12.94
2025 Q3 REDUCED 88,200 -2,047,189 -95.9% 0.00% $1.3M 2025-11-14 $11.58
2025 Q3 ADDED 2,135,389 +2,087,489 +4358.0% 0.00% $30.4M 2025-11-14 $11.58
2025 Q3 REDUCED 47,900 -45,600 -48.8% 0.00% $682K 2025-11-14 $11.58
2025 Q2 REDUCED 93,500 -2,250,710 -96.0% 0.00% $880K 2025-08-14 $10.85
2025 Q2 ADDED 2,344,210 +2,281,910 +3662.8% 0.00% $22.1M 2025-08-14 $10.85
2025 Q2 ADDED 62,300 +1,500 +2.5% 0.00% $586K 2025-08-14 $10.85
2025 Q1 REDUCED 60,800 -18,300 -23.1% 0.00% $330K 2025-05-15 $5.72
2025 Q1 REDUCED 79,100 -2,206,989 -96.5% 0.00% $429K 2025-05-15 $5.72
2025 Q1 ADDED 2,286,089 +2,201,889 +2615.1% 0.00% $12.4M 2025-05-15 $5.72
2024 Q4 REDUCED 84,200 -2,382,666 -96.6% 0.00% $627K 2025-02-14 $6.50
2024 Q4 ADDED 2,466,866 +2,430,866 +6752.4% 0.00% $18.4M 2025-02-14 $6.50
2024 Q4 REDUCED 36,000 -54,200 -60.1% 0.00% $268K 2025-02-14 $6.50
2024 Q3 REDUCED 90,200 -1,317,153 -93.6% 0.00% $721K 2024-11-14 $10.49
2024 Q3 ADDED 1,407,353 +1,365,753 +3283.1% 0.00% $11.2M 2024-11-14 $10.49
2024 Q3 REDUCED 41,600 -1,312,932 -96.9% 0.00% $332K 2024-11-14 $10.49
2024 Q2 ADDED 1,354,532 +1,231,832 +1003.9% 0.00% $11.8M 2024-08-14 $7.58
2024 Q2 ADDED 122,700 +23,200 +23.3% 0.00% $1.1M 2024-08-14 $7.58
2024 Q2 ADDED 99,500 +4,200 +4.4% 0.00% $866K 2024-08-14 $7.58
2024 Q1 ADDED 95,300 +7,800 +8.9% 0.00% $2.0M 2024-05-15 $12.94
2024 Q1 REDUCED 87,500 -1,288,017 -93.6% 0.00% $1.8M 2024-05-15 $12.94
2024 Q1 ADDED 1,375,517 +148,239 +12.1% 0.01% $28.4M 2024-05-15 $12.94
2023 Q4 ADDED 1,227,278 +728,478 +146.0% 0.01% $28.4M 2024-02-14 $28.92
2023 Q4 ADDED 498,800 +453,400 +998.7% 0.00% $11.5M 2024-02-14 $28.92
2023 Q4 ADDED 45,400 +16,300 +56.0% 0.00% $1.0M 2024-02-14 $28.92
29 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding EYPT

As of 2025 Q4 — sorted by position size

Cormorant Asset Management, LP 3Y 7Y 6.98% Essex Woodlands Management, Inc. 3Y 7Y 6.23% Principia Wealth Advisory, LLC 6.06% 5AM Venture Management, LLC 3Y 6.03% Spruce Street Capital LP 5.93% Rosalind Advisors, Inc. 4.43% Patient Square Capital LP 3Y 3.05% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.93% TCG Crossover Management, LLC 3Y 2.16% Artia Global Partners LP 3Y 1.99%

FAQ About CITADEL ADVISORS LLC and EYPT

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning EYPT?

CITADEL ADVISORS LLC reported EYPT across 26 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported EYPT position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for EYPT was 0.01% in 2023 Q4.

What is the latest reported EYPT position on this page?

The most recent filing on this page is 2025 Q4, when CITADEL ADVISORS LLC reported 63,200 shares, equal to 0.00% of portfolio, with an estimated market value of $1.2M.

What does the chart on this EYPT ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly EYPT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CITADEL ADVISORS LLC Holdings